Journal of Medicinal Chemistry
Page 18 of 21
(2)
World
Health
Organization
(WHO).
Cancer.
Kalinowski, D. S.; Richardson, D. R., Novel Chelators for Cancer
Treatment: Where are we now? Antioxid. Redox Signaling 2013, 18
(8), 973-1006; (d) Rafique, S.; Idrees, M.; Nasim, A.; Akbar, H.;
Athar, A., Transition Metal Complexes as Potential Therapeutic
Agent. Biotechnol. Mol. Biol. Rev. 2010, 5 (2), 38-45.
(accessed Jun 14, 2019).
1
2
3
4
5
6
7
8
(3) Kinch, M. S., An Analysis of FDA-approved Drugs for
Oncology. Drug Discovery Today 2014, 19 (12), 1831-1835.
(4) (a) Newman, D. J.; Cragg, G. M., Natural Products as Sources
of New Drugs from 1981 to 2014. J. Nat. Prod. 2016, 79 (3), 629-
661; (b) Harvey, A. L., Natural Products in Drug Discovery. Drug
Discovery Today 2008, 13 (19), 894-901; (c) Gordaliza, M., Natural
Products as Leads to Anticancer drugs. Clin. Transl. Oncol. 2007, 9
(12), 767-776.
(5) (a) Minois, N., Molecular Basis of the 'Anti-aging' Effect of
Spermidine and other Natural Polyamines - a mini-review.
Gerontology 2014, 60 (4), 319-326; (b) Muth, A.; Kamel, J.; Kaur, N.;
Shicora, A. C.; Ayene, I. S.; Gilmour, S. K.; Phanstiel, O., Development
of Polyamine Transport Ligands with Improved Metabolic Stability
and Selectivity Against Specific Human Cancers. J. Med. Chem.
2013, 56 (14), 5819-5828; (c) Nowotarski, S. L.; Woster, P. M.;
Casero, R. A., Jr., Polyamines and Cancer: Implications for
Chemotherapy and Chemoprevention. Expert. Rev. Mol. Med. 2013,
15, e3; (d) Gerner, E. W.; Meyskens, F. L., Jr., Polyamines and
Cancer: Old Molecules, New Understanding. Nat. Rev. Cancer 2004,
4 (10), 781-792.
(9) (a) Yu, Y.; Gutierrez, E.; Kovacevic, Z.; Saletta, F.; Obeidy, P.;
Suryo Rahmanto, Y.; Richardson, D. R., Iron Chelators for the
Treatment of Cancer. Curr. Med. Chem. 2012, 19 (17), 2689-2702;
(b) Fatfat, M.; Merhi, R. A.; Rahal, O.; Stoyanovsky, D. A.; Zaki, A.;
Haidar, H.; Kagan, V. E.; Gali-Muhtasib, H.; Machaca, K., Copper
Chelation Selectively Kills Colon Cancer Cells Through Redox
Cycling and Generation of Reactive Oxygen Species. BMC Cancer
2014, 14 (1), 1-12; (c) Santini, C.; Pellei, M.; Gandin, V.; Porchia, M.;
Tisato, F.; Marzano, C., Advances in Copper Complexes as
Anticancer Agents. Chem. Rev. 2014, 114 (1), 815-862; (d)
Hyvonen, M. T.; Ucal, S.; Pasanen, M.; Peraniemi, S.; Weisell, J.;
Khomutov, M.; Khomutov, A. R.; Vepsalainen, J.; Alhonen, L.;
Keinanen, T. A., Triethylenetetramine Modulates Polyamine and
Energy Metabolism and Inhibits Cancer Cell Proliferation. Biochem.
J. 2016, 473 (10), 1433-1441.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(10) Franklin, R. B.; Costello, L. C., The Important Role of the
Apoptotic Effects of Zinc in the Development of Cancers. J. Cell.
Biochem. 2009, 106 (5), 750-757.
(6) Bolognesi, M. L.; Minarini, A.; Budriesi, R.; Cacciaguerra, S.;
Chiarini, A.; Spampinato, S.; Tumiatti, V.; Melchiorre, C., Universal
Template Approach to Drug Design: Polyamines as Selective
Muscarinic Receptor Antagonists. J. Med. Chem. 1998, 41 (21),
4150-4160. (b) Casero, R.A.; Stewart, T.; Pegg, A.E., Polyamine
Metabolism and Cancer: Treatments, Challenges and
Opportunities. Nat. Rev. Cancer 2018, 18, 681-695. (c) Bae, D.H.;
Lane, D.J.R.; Jansson, P.J.; Richardson, D.R., The Old and New
Biochemistry of Polyamines. Biochim. Biophys. Acta Gen. Subj.
2018, 1862, 2053–2068.
(11) (a) Hashemi, M.; Ghavami, S.; Eshraghi, M.; Booy, E. P.; Los,
M., Cytotoxic effects of intra and extracellular zinc chelation on
human breast cancer cells. Eur. J. Pharmacol. 2007, 557 (1), 9-19;
(b) Hyun, H. J.; Sohn, J. H.; Ha, D. W.; Ahn, Y. H.; Koh, J. Y.; Yoon, Y.
H., Depletion of Intracellular Zinc and Copper with TPEN Results in
Apoptosis of Cultured Human Retinal Pigment Epithelial Cells.
Invest. Ophthalmol. Visual Sci. 2001, 42 (2), 460-465. (c) Nakatani,
T.; Tawaramoto, M.; Kennedy, D.O.; Kojima, A.; Matsui-Yuasa, I.,
Apoptosis Induced by Chelation of Intracellular Zinc is Associated
with Depletion of Cellular Reduced Glutathione Level in Rat
Hepatocytes. Chem-Biol. Interact. 2000, 125 (3), 151-163.
(12) (a) Silva, T. M.; Fiuza, S. M.; Marques, M. P.; Persson, L.;
Oredsson, S., Increased Breast Cancer Cell Toxicity by Palladination
of the Polyamine Analogue N1,N11-bis(ethyl)norspermine. Amino
Acids 2014, 46 (2), 339-352; (b) Corcé, V.; Renaud, S.; Cannie, I.;
Julienne, K.; Gouin, S. G.; Loréal, O.; Gaboriau, F.; Deniaud, D.,
Synthesis and Biological Properties of Quilamines II, New Iron
Chelators with Antiproliferative Activities. Bioconjugate Chem.
2014, 25 (2), 320-334; (c) Åstrand, O. A. H.; Aziz, G.; Ali, S. F.;
Paulsen, R. E.; Hansen, T. V.; Rongved, P., Synthesis and Initial in
vitro Biological Evaluation of Two New Zinc-Chelating
Compounds: Comparison with TPEN and PAC-1. Bioorg. Med. Chem.
2013, 21 (17), 5175-5181; (d) Rojas-Valencia, L.; Velez-Pardo, C.;
Jimenez-Del-Rio, M., Metal Chelator TPEN Selectively Induces
Apoptosis in K562 Cells through Reactive Oxygen Species Signaling
Mechanism: Implications for Chronic Myeloid Leukemia. BioMetals
2017, 30 (3), 405-421.
(7) (a) Dai, F.; Li, Q.; Wang, Y.; Ge, C.; Feng, C.; Xie, S.; He, H.; Xu,
X.; Wang, C., Design, Synthesis, and Biological Evaluation of
Mitochondria-Targeted
Flavone-Naphthalimide-Polyamine
Conjugates with Antimetastatic Activity. J. Med. Chem. 2017, 60 (5),
2071-2083; (b) Milelli, A.; Marchetti, C.; Greco, M. L.; Moraca, F.;
Costa, G.; Turrini, E.; Catanzaro, E.; Betari, N.; Calcabrini, C.; Sissi, C.;
Alcaro, S.; Fimognari, C.; Tumiatti, V.; Minarini, A., Naphthalene
Diimide-Polyamine Hybrids as Antiproliferative Agents: Focus on
the Architecture of the Polyamine Chains. Eur. J. Med. Chem. 2017,
128, 107-122; (c) Moosa, B. A.; Sagar, S.; Li, S.; Esau, L.; Kaur, M.;
Khashab, N. M., Synthesis and Anticancer Evaluation of
Spermatinamine Analogues. Bioorg. Med. Chem. Lett. 2016, 26 (6),
1629-1632; (d) Weisell, J.; Hyvonen, M. T.; Alhonen, L.;
Vepsalainen, J.; Keinanen, T. A.; Khomutov, A. R., Charge Deficient
Analogues of the Natural Polyamines. Curr. Pharm. Des. 2014, 20
(2), 262-277; (e) Pasini, A.; Caldarera, C. M.; Giordano, E.,
Chromatin Remodeling by Polyamines and Polyamine Analogs.
Amino Acids 2014, 46 (3), 595-603; (f) Minarini, A.; Zini, M.; Milelli,
A.; Tumiatti, V.; Marchetti, C.; Nicolini, B.; Falconi, M.; Farruggia, G.;
Cappadone, C.; Stefanelli, C., Synthetic Polyamines Activating
Autophagy: Effects on Cancer Cell Death. Eur. J. Med. Chem. 2013,
67, 359-366; (g) Polyamine Drug Discovery; Woster, P., Casero R.,
Eds.; Drug Discovery Series; Royal Society of Chemistry: RSC
Publishing, 2012; (h) Minarini, A.; Milelli, A.; Tumiatti, V.; Rosini,
M.; Bolognesi, M. L.; Melchiorre, C., Synthetic Polyamines: An
Overview of their Multiple Biological Activities. Amino Acids 2010,
38 (2), 383-392; (i) Casero, R. A.; Woster, P. M., Recent Advances in
the Development of Polyamine Analogues as Antitumor Agents. J.
Med. Chem. 2009, 52 (15), 4551-4573.
(13) (a) Makhov, P.; Golovine, K.; Uzzo, R. G.; Rothman, J.;
Crispen, P. L.; Shaw, T.; Scoll, B. J.; Kolenko, V. M., Zinc Chelation
Induces Rapid Depletion of the X-linked Inhibitor of Apoptosis and
Sensitizes Prostate Cancer Cells to TRAIL-Mediated Apoptosis. Cell
Death Differ. 2008, 15 (11), 1745–1751; (b) Zhu, B.; Wang, J.; Zhou,
F.; Liu, Y.; Lai, Y.; Wang, J.; Chen, X.; Chen, D.; Luo, L.; Hua, Z. C., Zinc
Depletion by TPEN Induces Apoptosis in Human Acute
Promyelocytic NB4 Cells. Cell. Physiol. Biochem. 2017, 42 (5), 1822-
1836.
(14) Aceves-Luquero, C.; Galiana-Roselló, C.; Ramis, G.;
Villalonga-Planells, R.; García-España, E.; Fernández de Mattos, S.;
Pélaez, R.; Llinares, J. M.; González-Rosende, M. E.; Villalonga, P., N-
(8) (a) Merlot, A. M.; Kalinowski, D. S.; Kovacevic, Z.; Jansson, P.
J.; Sahni, S.; Huang, M. L.; Lane, D. J. R.; Lok, H.; Richardson, D. R.,
Exploiting Cancer Metal Metabolism using Anti-Cancer Metal-
Binding Agents. Curr. Med. Chem. 2019, 26 (2), 302-322; (b) Kang,
C. S.; Ren, S.; Sun, X.; Chong, H. S., Theranostic
(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide:
A
Novel
Reversible Antimitotic Agent Inhibiting Cancer Cell Motility.
Biochem. Pharmacol. 2016, 115, 28-42.
(15) Aucejo, R.; Alarcón, J.; García-España, E.; Llinares, J. M.;
Marchin, K. L.; Soriano, C.; Lodeiro, C.; Bernardo, M. A.; Pina, F.;
Pina, J.; de Melo, J., A New ZnII Tweezer Pyridine-Naphthalene
System - An off-on-off System Working in a Biological pH Window.
Eur. J. Inorg. Chem. 2005, 4301-4308.
Polyaminocarboxylate-Cyanine-Transferrin
Conjugate
for
Anticancer Therapy and Near-Infrared Optical Imaging.
ChemMedChem 2016, 11 (19), 2188-2193; (c) Merlot, A. M.;
ACS Paragon Plus Environment